JP2011528662A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528662A5 JP2011528662A5 JP2011518898A JP2011518898A JP2011528662A5 JP 2011528662 A5 JP2011528662 A5 JP 2011528662A5 JP 2011518898 A JP2011518898 A JP 2011518898A JP 2011518898 A JP2011518898 A JP 2011518898A JP 2011528662 A5 JP2011528662 A5 JP 2011528662A5
- Authority
- JP
- Japan
- Prior art keywords
- aryl
- alkyl
- heteroaryl
- heterocycloalkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003118 aryl group Chemical group 0.000 claims 48
- 229910052799 carbon Inorganic materials 0.000 claims 24
- 125000001072 heteroaryl group Chemical group 0.000 claims 24
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 22
- 125000003710 aryl alkyl group Chemical group 0.000 claims 18
- 125000000753 cycloalkyl group Chemical group 0.000 claims 18
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 18
- 229910052739 hydrogen Inorganic materials 0.000 claims 16
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 12
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- -1 2-phenylethenyl Chemical group 0.000 claims 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- 208000017604 Hodgkin disease Diseases 0.000 claims 4
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000000266 alpha-aminoacyl group Chemical group 0.000 claims 4
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 4
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 4
- 125000001475 halogen functional group Chemical group 0.000 claims 4
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 229940121372 histone deacetylase inhibitor Drugs 0.000 claims 3
- 239000003276 histone deacetylase inhibitor Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000004442 acylamino group Chemical group 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 210000001165 lymph node Anatomy 0.000 claims 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 208000030289 Lymphoproliferative disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- FPOHNWQLNRZRFC-ZHACJKMWSA-N panobinostat Chemical compound CC=1NC2=CC=CC=C2C=1CCNCC1=CC=C(\C=C\C(=O)NO)C=C1 FPOHNWQLNRZRFC-ZHACJKMWSA-N 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8180508P | 2008-07-18 | 2008-07-18 | |
| US61/081,805 | 2008-07-18 | ||
| PCT/US2009/050768 WO2010009280A1 (en) | 2008-07-18 | 2009-07-16 | Use of hdac inhibitors for the treatment of hodgkin's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011528662A JP2011528662A (ja) | 2011-11-24 |
| JP2011528662A5 true JP2011528662A5 (OSRAM) | 2012-08-30 |
Family
ID=41128203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011518898A Pending JP2011528662A (ja) | 2008-07-18 | 2009-07-16 | ホジキン病の治療のためのｈｄａｃ阻害剤の使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110118309A1 (OSRAM) |
| EP (1) | EP2306996A1 (OSRAM) |
| JP (1) | JP2011528662A (OSRAM) |
| KR (1) | KR20110031980A (OSRAM) |
| CN (1) | CN102099021A (OSRAM) |
| AU (1) | AU2009270886A1 (OSRAM) |
| BR (1) | BRPI0915927A2 (OSRAM) |
| CA (1) | CA2730738A1 (OSRAM) |
| CL (1) | CL2011000100A1 (OSRAM) |
| IL (1) | IL210489A0 (OSRAM) |
| MA (1) | MA32482B1 (OSRAM) |
| MX (1) | MX2011000719A (OSRAM) |
| TW (1) | TW201006470A (OSRAM) |
| WO (1) | WO2010009280A1 (OSRAM) |
| ZA (1) | ZA201100165B (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2630306T3 (es) * | 2011-07-07 | 2017-08-21 | Research Cancer Institute Of America | Sistemas, métodos, y formulaciones para tratar el cáncer |
| US8933078B2 (en) | 2011-07-14 | 2015-01-13 | Research Cancer Institute Of America | Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances |
| US11890292B2 (en) | 2017-02-27 | 2024-02-06 | Research Cancer Institute Of America | Compositions, methods, systems and/or kits for preventing and/or treating neoplasms |
| WO2018170457A1 (en) | 2017-03-17 | 2018-09-20 | Research Cancer Institute Of America | Compositions, methods, systems and/or kits for preventing and/or treating neoplasms |
| CN109705057B (zh) * | 2017-10-25 | 2023-05-30 | 成都先导药物开发股份有限公司 | 组蛋白去乙酰化酶抑制剂及其制备方法与用途 |
| EP3710434A4 (en) | 2017-11-17 | 2021-07-28 | Research Cancer Institute of America | COMPOSITIONS, METHODS, SYSTEMS AND / OR KITS FOR THE PREVENTION AND / OR TREATMENT OF NEOPLASMS |
| AU2020379812A1 (en) * | 2019-11-06 | 2022-03-31 | Dana-Farber Cancer Institute, Inc. | Selective dual histone deacetylase 6/8 (HDAC6/8) degraders and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020354A1 (es) * | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
| US20100008923A1 (en) * | 2006-06-26 | 2010-01-14 | Novartis Ag | Organic Compounds |
| AU2007328281B2 (en) * | 2006-12-04 | 2011-03-31 | Novartis Ag | Combination of an HDAC inhibitor and an antimetabolite |
-
2009
- 2009-07-16 MX MX2011000719A patent/MX2011000719A/es not_active Application Discontinuation
- 2009-07-16 AU AU2009270886A patent/AU2009270886A1/en not_active Abandoned
- 2009-07-16 WO PCT/US2009/050768 patent/WO2010009280A1/en not_active Ceased
- 2009-07-16 KR KR1020117003661A patent/KR20110031980A/ko not_active Withdrawn
- 2009-07-16 JP JP2011518898A patent/JP2011528662A/ja active Pending
- 2009-07-16 EP EP09790500A patent/EP2306996A1/en not_active Withdrawn
- 2009-07-16 CA CA2730738A patent/CA2730738A1/en not_active Abandoned
- 2009-07-16 CN CN2009801279739A patent/CN102099021A/zh active Pending
- 2009-07-16 US US13/054,528 patent/US20110118309A1/en not_active Abandoned
- 2009-07-16 BR BRPI0915927A patent/BRPI0915927A2/pt not_active Application Discontinuation
- 2009-07-17 TW TW098124315A patent/TW201006470A/zh unknown
-
2011
- 2011-01-06 ZA ZA2011/00165A patent/ZA201100165B/en unknown
- 2011-01-06 IL IL210489A patent/IL210489A0/en unknown
- 2011-01-14 MA MA33526A patent/MA32482B1/fr unknown
- 2011-01-17 CL CL2011000100A patent/CL2011000100A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528662A5 (OSRAM) | ||
| JP2009504763A5 (OSRAM) | ||
| RU2488582C2 (ru) | Бициклозамещенные азопроизводные пиразолона, способ их получения и фармацевтическое применение | |
| JP2010524932A5 (OSRAM) | ||
| JP2013508279A5 (OSRAM) | ||
| JP2010511721A5 (OSRAM) | ||
| JP2010514832A5 (OSRAM) | ||
| JP2010526025A5 (OSRAM) | ||
| JP2010504343A5 (OSRAM) | ||
| JP2009529540A5 (OSRAM) | ||
| JP2010077141A5 (OSRAM) | ||
| JP2018135343A5 (OSRAM) | ||
| JP2007246474A5 (OSRAM) | ||
| JP2009535307A5 (OSRAM) | ||
| JP2009515988A5 (OSRAM) | ||
| JP2004516314A5 (OSRAM) | ||
| JP2010511626A5 (OSRAM) | ||
| JP2013537203A5 (OSRAM) | ||
| JP2011500658A5 (OSRAM) | ||
| JP2013503846A5 (OSRAM) | ||
| JP2009507896A5 (OSRAM) | ||
| JP2013512277A5 (OSRAM) | ||
| JP2011513410A5 (OSRAM) | ||
| RU2009125439A (ru) | Комбинация ингибитора гда и антиметаболита | |
| JP2014505107A5 (OSRAM) |